Abstract | BACKGROUND: Attachment of leukemic cells to vascular endothelial cells induces the vascular endothelial cells to release endothelial cell-derived interleukin 8 (endothelial IL-8), which then induces leukemic cells to undergo apoptosis. NB4, a human promyelocytic leukemic cell line that expresses high levels of cell-surface CD13/ aminopeptidase N, does not undergo endothelial IL-8-induced apoptosis. Consequently, we investigated the relationship between cell-surface aminopeptidase activity and endothelial IL-8 induction of apoptosis in various leukemic cell lines. METHODS: CD13/ aminopeptidase N activity and IL-8-induced apoptosis were examined in leukemic cell lines. Endothelial IL-8-induced apoptosis was examined further in NB4 cells, K562 cells (human chronic myelogenous leukemic cells expressing low levels of CD13/ aminopeptidase N), CD13/ aminopeptidase N-transfected K562 (K562/CD13) cells that overexpress aminopeptidase, and mock-transfected K562 cells (vector only). These cells were also cocultured with a vascular endothelial cell layer to investigate the association between aminopeptidase activity and apoptosis in this system. All statistical tests were two-sided. RESULTS: Endothelial IL-8 induced apoptosis in K562 cells but not in K562/CD13 cells. A combination of an aminopeptidase inhibitor (such as bestatin) and endothelial IL-8 induced apoptosis in NB4 cells and K562/CD13 cells (2.88-fold difference [95% confidence interval [CI] = 1.82-fold to 3.94-fold], P =.004 for bestatin-treated NB4 cells and 4.31-fold difference [95% CI = 3.52-fold to 5.10-fold], P<.001 for bestatin-treated K562/CD13 cells). When aminopeptidase activity in NB4 cells was modulated by aminopeptidase inhibitors, a statistically significant correlation was found between aminopeptidase activity and the proportion of apoptotic cells induced by endothelial IL-8 ( r = -.837, P<.001 by Pearson's correlation coefficient; r = -.697, P =.013 by Spearman's correlation analysis by ranks). K562/CD13 cells cocultured with vascular endothelial cells did not undergo apoptosis, but the addition of bestatin resulted in the induction of apoptosis in K562/CD13 cells (2.70-fold difference [95% CI = 1.77-fold to 3.63-fold], P<.001). Bestatin treatment increased the level of IL-8 mRNA in and the amount of IL-8 secreted by vascular endothelial cells. CONCLUSIONS: High levels of cell-surface CD13/ aminopeptidase N appear to allow leukemic cells to resist endothelial IL-8-induced apoptosis. The combination of endothelial IL-8 and bestatin induce leukemic cells expressing high levels of CD13/ aminopeptidase N to undergo apoptosis. Bestatin may be useful for treating patients with leukemia.
|
Authors | Yuji Mishima, Yuko Matsumoto-Mishima, Yasuhito Terui, Misa Katsuyama, Muneo Yamada, Masaki Mori, Yukihito Ishizaka, Kazuma Ikeda, Jun-ichiro Watanabe, Nobuyuki Mizunuma, Hirotoshi Hayasawa, Kiyohiko Hatake |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 94
Issue 13
Pg. 1020-8
(Jul 03 2002)
ISSN: 0027-8874 [Print] United States |
PMID | 12096087
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Interleukin-8
- CD13 Antigens
- Leucine
- ubenimex
|
Topics |
- Antibiotics, Antineoplastic
(pharmacology)
- Apoptosis
(drug effects, physiology)
- Blotting, Northern
- CD13 Antigens
(antagonists & inhibitors, genetics, metabolism)
- Cell Division
(drug effects)
- Cells, Cultured
- Endothelium, Vascular
(physiology)
- Fluorescent Antibody Technique
- Humans
- In Situ Nick-End Labeling
- Interleukin-8
(metabolism, pharmacology, physiology)
- K562 Cells
(pathology)
- Leucine
(analogs & derivatives, pharmacology)
- Leukemia
(pathology)
- Transfection
- Umbilical Veins
|